Valeant Pharmaceuticals International (NYSE:VRX) today announced that it
will host a conference call on Thursday, November 6, 2008 at 10:00 a.m.
EST (7:00 a.m. PST) to discuss results for the 2008 third quarter.
The dial-in number to participate on this call is (877) 295-5743,
confirmation code 65404497. International callers should dial
(706) 679-0845, confirmation code 65404497. A replay will be available
approximately two hours following the conclusion of the conference call
to Thursday, November 13, 2008, and can be accessed by dialing (800)
642-1687 or (706) 645-9291, confirmation code 65404497.
The company also will webcast the call live over the Internet, which
will be hosted in the investor relations section of its corporate Web
site at www.valeant.com.
Participants should allow approximately five to 10 minutes prior to the
call’s start time to visit the site and to
download any streaming media software needed to listen to the Internet
webcast. An online archive of the webcast will be available following
the end of the live call in the webcast archive portion of the investor
relations section at www.valeant.com.
About Valeant
Valeant Pharmaceuticals International (NYSE:VRX) is a multinational
specialty pharmaceutical company that develops, manufactures and markets
a broad range of pharmaceutical products primarily in the areas of
neurology and dermatology. More information about Valeant can be found
at www.valeant.com.
Valeant Pharmaceuticals
Laurie W. Little, 949-461-6002
